A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

572

Participants

Timeline

Start Date

April 6, 2022

Primary Completion Date

November 22, 2022

Study Completion Date

November 22, 2022

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

mRNA-1030

Sterile liquid for injection

BIOLOGICAL

mRNA-1020

Sterile liquid for injection

BIOLOGICAL

mRNA-1010

Sterile liquid for injection

BIOLOGICAL

Active Comparator

Sterile liquid for injection

Trial Locations (15)

13760

Meridian Clinical Research, Endwell

28403

Trial Management Associates, LLC, Wilmington

28557

Lucas Research, Morehead City

31904

IACT Health, Columbus

33134

Alliance for MultiSpecialty Research, Coral Gables

33458

Health Awareness, Inc., Jupiter

45246

Meridian Clinical Research, Cincinnati

51106

Meridian Clinical Research, Sioux City

63141

Sundance Clinical Research, LLC, St Louis

67207

Heartland Research Associates, LLC, Wichita

73072

Lynn Institute of Norman, Norman

77584

LinQ Research, LLC, Pearland

84117

Olympus Family Medicine, Salt Lake City

84405

South Ogden Family Medicine, South Ogden

85044

Foothills Research Center, Phoenix

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY